Topic Hub

Metformin — Regulatory History

5 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.

5articles

35keywords mapped

2026-05-26latest review

Explore

Metformin — Regulatory History library

Showing 5 of 5 clinical reviews.

Comparisons2026-05-26

Metformin EMA vs FDA Approach: How Two Regulators Govern the World's Most Prescribed Diabetes Drug

A side-by-side comparison of how the FDA and EMA regulate metformin, including approval history, label differences, renal thresholds, safety monitoring, and post-market surveillance.

Read clinical review

Safety2026-05-26

Metformin FAERS Safety Signals: Post-Market Surveillance Data and FDA Reporting Trends

A clinical review of metformin safety signals in the FDA Adverse Event Reporting System (FAERS), including lactic acidosis, B12 deficiency, NDMA contamination, and updated renal dosing guidance.

Read clinical review

Clinical Reviews2026-05-26

Metformin FDA Approval History: From European Staple to America's Most Prescribed Diabetes Drug

A complete timeline of metformin's FDA approval, label expansions, safety reviews, and regulatory milestones from 1994 to the present day.

Read clinical review

Safety2026-05-26

Metformin Global Regulatory Status: FDA Approval, International Labels, and Post-Market Safety

A complete overview of metformin's regulatory history across the FDA, EMA, and other global agencies, including approval timelines, labeling updates, NDMA concerns, and current prescribing status.

Read clinical review

Safety2026-05-25

Metformin Label Updates 2020-2026: FDA Safety Changes, Renal Thresholds, and NDMA Recalls

A complete timeline of metformin FDA label changes from 2020 through 2026, including the eGFR renal threshold expansion, NDMA impurity recalls, vitamin B12 monitoring, and updated lactic acidosis language.

Read clinical review